Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
Evolve Global Healthcare Enhanced Yield Fund Hedged Class A
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade D
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade A
Click for more information on Fundata’s ESG Grade.
|
NAVPS (05-13-2026) |
$13.55 |
|---|---|
| Change |
$0.04
(0.30%)
|
As at April 30, 2026
As at April 30, 2026
As at April 30, 2026
Loading......
Legend
Compare Options
Fund Returns
Inception Return (July 07, 2020): 4.23%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -3.47% | -9.54% | -3.48% | -8.11% | 0.38% | 0.26% | 1.39% | 2.29% | 3.79% | - | - | - | - | - |
| Benchmark | -2.20% | -5.11% | -0.92% | -4.87% | 5.78% | 3.80% | 4.47% | 5.87% | 5.46% | 5.98% | 7.70% | 8.37% | 7.92% | 8.80% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 40 / 53 | 44 / 51 | 35 / 51 | 37 / 51 | 36 / 51 | 34 / 49 | 26 / 43 | 27 / 41 | 17 / 39 | - | - | - | - | - |
| Quartile Ranking | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | - | - | - | - | - |
Monthly Return
| Return % | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -1.86% | -0.22% | -0.77% | 3.20% | -0.27% | 4.00% | 7.05% | -1.87% | 1.57% | 0.49% | -6.74% | -3.47% |
| Benchmark | -3.48% | 0.91% | -0.60% | 4.16% | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% |
Best Monthly Return Since Inception
8.06% (October 2022)
Worst Monthly Return Since Inception
-6.78% (August 2022)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | 18.13% | -0.62% | 2.99% | 1.08% | 11.44% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | 2 | 2 | 2 | 4 | 2 |
| Category Rank | - | - | - | - | - | 18/ 38 | 18/ 40 | 11/ 41 | 44/ 48 | 16/ 50 |
Best Calendar Return (Last 10 years)
18.13% (2021)
Worst Calendar Return (Last 10 years)
-0.62% (2022)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 63.70 |
| International Equity | 34.40 |
| Cash and Equivalents | 1.90 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 98.33 |
| Cash and Cash Equivalent | 1.90 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 65.60 |
| Europe | 34.48 |
Top Holdings
| Name | Percent |
|---|---|
| Novo Nordisk A/S - ADR | 5.71 |
| Abbvie Inc | 5.24 |
| Bristol-Myers Squibb Co | 5.16 |
| Intuitive Surgical Inc | 5.08 |
| Roche Holding AG - ADR | 5.08 |
| Pfizer Inc | 5.03 |
| Sanofi SA - ADR | 5.02 |
| Eli Lilly and Co | 5.01 |
| Amgen Inc | 4.99 |
| Johnson & Johnson | 4.94 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
Evolve Global Healthcare Enhanced Yield Fund Hedged Class A
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 12.33% | 13.00% | - |
|---|---|---|---|
| Beta | 0.98 | 1.00 | - |
| Alpha | -0.03 | -0.01 | - |
| Rsquared | 0.82% | 0.82% | - |
| Sharpe | -0.12 | 0.13 | - |
| Sortino | -0.10 | 0.17 | - |
| Treynor | -0.02 | 0.02 | - |
| Tax Efficiency | - | - | - |
| Volatility |
|
|
- |
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 12.53% | 12.33% | 13.00% | - |
| Beta | 0.88 | 0.98 | 1.00 | - |
| Alpha | -0.05 | -0.03 | -0.01 | - |
| Rsquared | 0.86% | 0.82% | 0.82% | - |
| Sharpe | -0.10 | -0.12 | 0.13 | - |
| Sortino | -0.22 | -0.10 | 0.17 | - |
| Treynor | -0.01 | -0.02 | 0.02 | - |
| Tax Efficiency | - | - | - | - |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | July 07, 2020 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Monthly |
| Assets ($mil) | - |
Fund Codes
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| EVF171 |
Investment Objectives
LIFE seeks to replicate, to the extent reasonably possible before fees and expenses, the performance of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while mitigating downside risk. LIFE invests primarily in the equity constituents of the Solactive Global Healthcare 20 Index Canadian Dollar Hedged, or any successor thereto, while writing covered call options on up to 33% of the portfolio securities, at the discretion of the Manager.
Investment Strategy
In order to achieve its investment objective and to obtain direct or indirect exposure to the Constituent Securities of the applicable Index, each Evolve Fund may hold the Constituent Securities of the applicable Index in approximately the same proportion as they are reflected in that Index or may hold securities of one or more exchange traded funds that replicate the performance of the applicable Index, or a subset of such Index.
Portfolio Management
| Portfolio Manager |
Evolve Funds Group Inc. |
|---|---|
| Sub-Advisor |
- |
Management and Organization
| Fund Manager |
Evolve Funds Group Inc. |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
Investment Minimums
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 500 |
| PAC Subsequent | 0 |
| SWP Allowed | No |
| SWP Min Balance | - |
| SWP Min Withdrawal | - |
Fees
| MER | 1.80% |
|---|---|
| Management Fee | 1.45% |
| Load | Back Fee Only |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
